Photodynamic therapy evaluation of methoxypolyethyleneglycol-thiol-SPIONs-gold-meso-tetrakis(4-hydroxyphenyl)porphyrin conjugate against breast cancer cells-Reference-Cited by-同舟云学术

Photodynamic therapy evaluation of methoxypolyethyleneglycol-thiol-SPIONs-gold-meso-tetrakis(4-hydroxyphenyl)porphyrin conjugate against breast cancer cells

Published:2018-11 Issue: Volume:92 Page:737-744
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Fakayode O.J.,Kruger C.A.,Songca S.P.,Abrahamse H.,Oluwafemi O.S.

Funder

National Research Foundation

University of Johannesburg

Department of Science and Technology

Publisher

Elsevier BV

Reference46 articles.

1. Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview;Chiaviello;Cancers (Basel),2011

2. Synthesis and characterization of gold nanostructured Chorin e6 for photodynamic therapy;Vieira;Photodiagn. Photodyn. Ther.,2017

3. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer;Wang;ACS Nano,2014

4. Magnetic targeting of novel heparinized iron oxide nanoparticles evaluated in a 9L-glioma mouse model;Zhang;Pharm. Res.,2014

5. Studies on preparation of photosensitizer loaded magnetic silica nanoparticles and their anti-tumor effects for targeting photodynamic therapy;Chen;Nanoscale Res. Lett.,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart SPIONs for Multimodal Cancer Theranostics: A Review;Molecular Pharmaceutics;2025-04-14

2. Design and characterization of novel A2B2 porphyrins: Solar cell applications, antimicrobial properties, and molecular docking insights;Journal of Molecular Structure;2025-02

3. Experimental and clinical combined photodynamic therapy for malignant and premalignant lesions using various types of radiation;Siberian journal of oncology;2024-09-09

4. The research trends and future prospects of nanomaterials in breast cancer;Cancer Nanotechnology;2024-04-25

5. Combinations of meso-(4-carboxyphenyl) and meso-(4- hydroxyphenyl) porphyrins as anti-HIV-1 agents;2024-03-06